PPARGC1A and Huntington disease: Given its role in mitochondrial function, protein turnover, and myelination, enhancing PGC-1α activity has emerged as a promising therapeutic strategy for early intervention in HD, offering potential benefits for both neuronal maintenance and metabolic homeostasis.